From: Five-years surveillance of invasive aspergillosis in a university hospital
underlying diseases/therapy | proven + probable IA n = 81 | total (all proven and probable cases) (%) |
---|---|---|
tumor diseases | 10 | 12.3% |
   colorectal cancer (colectomy, rectal resection) | 4 | 4.9% |
   gastric cancer (gastrectomy) | 2 | 2.5% |
   cholangiocarcinoma (tumor resection) | 1 | 1.2% |
   hepatocellular carcinoma | 2 | 2.5% |
   renal carcinoma (nephrectomy) | 1 | 1.2% |
other diseases | 26 | 32.5% |
   gastroenterologic diseases | 10 | 12.3% |
   necrotizing enterocolitis | 1 | 1.2% |
   necrotizing pancreatitis | 2 | 2.5% |
   chronical hepatitis B infection | 3 | 3.7% |
   liver cirrhosis | 3 | 3.7% |
   citrullinaemia | 1 | 1.2% |
   prematurity | 1 | 1.2% |
heart diseases | 4 | 4.9% |
   congenital heart disease | 1 | 1.2% |
   dilatative cardiomyopathy | 2 | 2.5% |
   endocarditis | 1 | 1.2% |
vascular diseases | 1 | 1.2% |
   type B dissection (stent implantation) | 1 | 1.2% |
renal diseases | 4 | 6.2% |
   renal insufficiency | 4 | 4.9% |
other diseases | 5 | 6.2% |
   multiple trauma | 3 | 3.7% |
   sinusitis maxillaris | 2 | 2.5% |